Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1995-5-24
|
| pubmed:abstractText |
RTOG 83-07 is a Phase II randomized protocol designed to compare the efficacy and toxicity of Megestrol vs. Diethylstilbestrol (DES) used as cytoreductive agents prior to and during radiotherapy. The end points of this study include tumor clearance rate, effect on serum testosterone, loco-regional control, disease-free interval, and survival.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0360-3016
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
30
|
| pubmed:volume |
32
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
175-80
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:7721614-Adenocarcinoma,
pubmed-meshheading:7721614-Combined Modality Therapy,
pubmed-meshheading:7721614-Diethylstilbestrol,
pubmed-meshheading:7721614-Humans,
pubmed-meshheading:7721614-Male,
pubmed-meshheading:7721614-Megestrol,
pubmed-meshheading:7721614-Neoplasm Staging,
pubmed-meshheading:7721614-Prostatic Neoplasms,
pubmed-meshheading:7721614-Radiotherapy Dosage
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: outcome results of RTOG 83-07.
|
| pubmed:affiliation |
C. McAuley Health System, Ann Arbor, MI, USA.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Clinical Trial, Phase II
|